Proteomic identification of dopamine-conjugated proteins from isolated rat brain mitochondria and SH-SY5Y cells
暂无分享,去创建一个
Michael Cascio | M. Cascio | Victor S. Van Laar | V. V. Laar | Amanda Mishizen | T. Hastings | Amanda J. Mishizen | Teresa G. Hastings
[1] D F Hochstrasser,et al. Toward a clinical molecular scanner for proteome research: parallel protein chemical processing before and during western blot. , 1999, Analytical chemistry.
[2] G. Cortopassi,et al. Mitochondrial frataxin interacts with ISD11 of the NFS1/ISCU complex and multiple mitochondrial chaperones. , 2007, Human molecular genetics.
[3] T. Montine,et al. The Lipid Peroxidation Product 4‐Hydroxynonenal Inhibits Neurite Outgrowth, Disrupts Neuronal Microtubules, and Modifies Cellular Tubulin , 1999, Journal of neurochemistry.
[4] A. Schapira,et al. Mitochondrial involvement in Parkinson’s disease , 2002, Neurochemistry International.
[5] Georg Auburger,et al. The ubiquitin pathway in Parkinson's disease , 1998, Nature.
[6] Alisdair R Fernie,et al. Enzymes of Glycolysis Are Functionally Associated with the Mitochondrion in Arabidopsis Cells Article, publication date, and citation information can be found at www.plantcell.org/cgi/doi/10.1105/tpc.012500. , 2003, The Plant Cell Online.
[7] Rifat Hasan,et al. Peroxynitrite oxidation of tubulin sulfhydryls inhibits microtubule polymerization. , 2002, Archives of biochemistry and biophysics.
[8] J. Xie,et al. The mitochondrial inner membrane protein Mitofilin exists as a complex with SAM50, metaxins 1 and 2, coiled‐coil‐helix coiled‐coil‐helix domain‐containing protein 3 and 6 and DnaJC11 , 2007, FEBS letters.
[9] P. Jenner,et al. Oxidative stress in Parkinson's disease , 2003, Annals of neurology.
[10] I. Ziv,et al. Prevention of Dopamine-Induced Cell Death by Thiol Antioxidants: Possible Implications for Treatment of Parkinson's Disease , 1996, Experimental Neurology.
[11] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[12] W. Fischer,et al. Protein Disulfide Bond Formation in the Cytoplasm during Oxidative Stress* , 2004, Journal of Biological Chemistry.
[13] K. Vrana,et al. Dopamine, in the presence of tyrosinase, covalently modifies and inactivates tyrosine hydroxylase , 1998, Journal of neuroscience research.
[14] E. Jayatilleke,et al. Inhibition of brain mitochondrial respiration by dopamine: involvement of H2O2 and hydroxyl radicals but not glutathione–protein–mixed disulfides , 2002, Journal of neurochemistry.
[15] W. Neupert,et al. The mitochondrial proteins Ssq1 and Jac1 are required for the assembly of iron sulfur clusters in mitochondria. , 2001, Journal of molecular biology.
[16] M. LaVoie,et al. Dopamine Quinone Formation and Protein Modification Associated with the Striatal Neurotoxicity of Methamphetamine: Evidence against a Role for Extracellular Dopamine , 1999, The Journal of Neuroscience.
[17] T. Wallimann,et al. A conserved negatively charged cluster in the active site of creatine kinase is critical for enzymatic activity. , 2000, The Journal of biological chemistry.
[18] A. D. Jones,et al. Monocrotaline pyrrole targets proteins with and without cysteine residues in the cytosol and membranes of human pulmonary artery endothelial cells , 2005, Proteomics.
[19] G. Zeevalk,et al. Inhibition of brain mitochondrial respiration by dopamine and its metabolites: implications for Parkinson's disease and catecholamine‐associated diseases , 2004, Journal of neurochemistry.
[20] D. Butterfield,et al. Redox proteomic identification of 4-Hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: Insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease , 2008, Neurobiology of Disease.
[21] M. Zigmond,et al. Modification of Dopamine Transporter Function: Effect of Reactive Oxygen Species and Dopamine , 1996, Journal of neurochemistry.
[22] L. Elferink,et al. Tyrosine Hydroxylase Is Inactivated by Catechol‐Quinones and Converted to a Redox‐Cycling Quinoprotein , 1999, Journal of neurochemistry.
[23] R. Simantov,et al. Mitochondrial voltage‐dependent anion channel is involved in dopamine‐induced apoptosis , 2002, Journal of neurochemistry.
[24] T. Hirokawa,et al. Alterations of structure and hydrolase activity of parkinsonism-associated human ubiquitin carboxyl-terminal hydrolase L1 variants. , 2003, Biochemical and biophysical research communications.
[25] A. Torroni,et al. Mitochondrial oxidative phosphorylation defects in parkinson's disease , 1991, Annals of neurology.
[26] L. Bini,et al. Selectivity of protein carbonylation in the apoptotic response to oxidative stress associated with photodynamic therapy: a cell biochemical and proteomic investigation , 2004, Cell Death and Differentiation.
[27] S. Chakrabarti,et al. Dopamine induced protein damage in mitochondrial-synaptosomal fraction of rat brain , 2001, Brain Research.
[28] P. Ljubuncic,et al. Dopamine toxicity involves mitochondrial complex I inhibition: implications to dopamine-related neuropsychiatric disorders. , 2004, Biochemical pharmacology.
[29] T. Veenstra,et al. Identification of oxidized mitochondrial proteins in alcohol‐exposed human hepatoma cells and mouse liver , 2004, Proteomics.
[30] E. J. Song,et al. Oxidative modification of nucleoside diphosphate kinase and its identification by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. , 2000, Biochemistry.
[31] T. Miura,et al. Inactivation of creatine kinase induced by dopa and dopamine in the presence of ferrylmyoglobin. , 1999, Chemico-biological interactions.
[32] Kanefusa Kato,et al. Cerebrospinal fluid levels of superoxide dismutases in neurological diseases detected by sensitive enzyme immunoassays , 1994, Journal of the Neurological Sciences.
[33] Michael Cascio,et al. Changes in endoplasmic reticulum stress proteins and aldolase A in cells exposed to dopamine , 2008, Journal of neurochemistry.
[34] D. Tse,et al. Potential oxidative pathways of brain catecholamines. , 1976, Journal of medicinal chemistry.
[35] I. Boldogh,et al. Interactions of mitochondria with the actin cytoskeleton. , 2006, Biochimica et biophysica acta.
[36] B. Knoops,et al. Silencing of peroxiredoxin 3 and peroxiredoxin 5 reveals the role of mitochondrial peroxiredoxins in the protection of human neuroblastoma SH-SY5Y cells toward MPP+ , 2008, Neuroscience Letters.
[37] B. Halliwell,et al. Role of Free Radicals in the Neurodegenerative Diseases , 2001, Drugs & aging.
[38] M. Zigmond,et al. Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[39] S. Kaul,et al. Involvement of Mortalin in Cellular Senescence from the Perspective of its Mitochondrial Import, Chaperone, and Oxidative Stress Management Functions , 2007, Annals of the New York Academy of Sciences.
[40] R. Luduena,et al. Tubulin sulfhydryl groups as probes and targets for antimitotic and antimicrotubule agents. , 1991, Pharmacology & therapeutics.
[41] M. Cameron Sullards,et al. Oxidative Damage of DJ-1 Is Linked to Sporadic Parkinson and Alzheimer Diseases* , 2006, Journal of Biological Chemistry.
[42] Peter T. Lansbury,et al. Kinetic Stabilization of the α-Synuclein Protofibril by a Dopamine-α-Synuclein Adduct , 2001, Science.
[43] S. Ito,et al. Covalent binding of catechols to proteins through the sulphydryl group. , 1988, Biochemical pharmacology.
[44] B. Bergamasco,et al. Proteome analysis of human substantia nigra in Parkinson's disease , 2004, Proteomics.
[45] Y. Kato,et al. Effects of dopamine and L‐DOPA on survival of PC12 cells , 2000, Journal of neuroscience research.
[46] G. Perry,et al. Neurotoxic dopamine quinone facilitates the assembly of tau into fibrillar polymers , 2005, Molecular and Cellular Biochemistry.
[47] Nuzhat Ahmed,et al. Strategies for revealing lower abundance proteins in two-dimensional protein maps. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[48] L. Sweetlove,et al. Enolase takes part in a macromolecular complex associated to mitochondria in yeast. , 2006, Biochimica et biophysica acta.
[49] Rina Bandopadhyay,et al. The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease. , 2004, Brain : a journal of neurology.
[50] Allan I. Levey,et al. Oxidative Modifications and Down-regulation of Ubiquitin Carboxyl-terminal Hydrolase L1 Associated with Idiopathic Parkinson's and Alzheimer's Diseases* , 2004, Journal of Biological Chemistry.
[51] M. Kikuchi,et al. A Possible Role of ER-60 Protease in the Degradation of Misfolded Proteins in the Endoplasmic Reticulum (*) , 1995, The Journal of Biological Chemistry.
[52] M. Kito,et al. Catalytic cysteine residues of ER‐60 protease , 2000, FEBS letters.
[53] Barry Halliwell,et al. Oxidative stress and neurodegeneration: where are we now? , 2006, Journal of neurochemistry.
[54] H. Maker,et al. Amine-mediated toxicity The effects of dopamine, norepinephrine, 5-hydroxytryptamine, 6-hydroxydopamine, ascorbate, glutathione and peroxide on the in vitro activities of creatine and adenylate kinases in the brain of the rat , 1986, Neuropharmacology.
[55] K. Jellinger,et al. Unaltered aconitase activity, but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson's disease , 1994, Neuroscience Letters.
[56] E. Klein,et al. Dopamine modulates mitochondrial function in viable SH-SY5Y cells possibly via its interaction with complex I: relevance to dopamine pathology in schizophrenia. , 2008, Biochimica et biophysica acta.
[57] Dennis W Wilson,et al. Protein targets of 1,4‐benzoquinone and 1,4‐naphthoquinone in human bronchial epithelial cells , 2003, Proteomics.
[58] C. Marsden,et al. A Selective Increase in Particulate Superoxide Dismutase Activity in Parkinsonian Substantia Nigra , 1989, Journal of neurochemistry.
[59] R. Pietruszko,et al. Inactivation of aldehyde dehydrogenase in intact rat liver mitochondria by dopamine. , 1989, Alcohol.
[60] W. Strittmatter,et al. Mortalin is regulated by APOE in hippocampus of AD patients and by human APOE in TR mice , 2007, Neurobiology of Aging.
[61] J. T. Greenamyre,et al. Parkinson's--Divergent Causes, Convergent Mechanisms , 2004, Science.
[62] C. Marsden,et al. Mitochondrial Complex I Deficiency in Parkinson's Disease , 1990, Lancet.
[63] M. Kito,et al. Protein degradation by the phosphoinositide-specific phospholipase C-alpha family from rat liver endoplasmic reticulum. , 1992, The Journal of biological chemistry.
[64] D. Butterfield,et al. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. , 2002, Free radical biology & medicine.
[65] Todd B. Sherer,et al. Mechanism of Toxicity in Rotenone Models of Parkinson's Disease , 2003, The Journal of Neuroscience.
[66] Visith Thongboonkerd,et al. Proteomic identification of nitrated proteins in Alzheimer's disease brain , 2003, Journal of neurochemistry.
[67] Li Li,et al. The mitochondrial inner membrane protein mitofilin controls cristae morphology. , 2005, Molecular biology of the cell.
[68] Min Shi,et al. Biomarker discovery in neurodegenerative diseases: A proteomic approach , 2009, Neurobiology of Disease.
[69] I. Tarassov,et al. A glycolytic enzyme, enolase, is recruited as a cofactor of tRNA targeting toward mitochondria in Saccharomyces cerevisiae. , 2006, Genes & development.
[70] K. Vrana,et al. Cytotoxic and genotoxic potential of dopamine , 1999, Journal of neuroscience research.
[71] S. Berman,et al. Dopamine Oxidation Alters Mitochondrial Respiration and Induces Permeability Transition in Brain Mitochondria , 1999, Journal of neurochemistry.
[72] T. Montine,et al. Covalent Crosslinking of Neurofilament Proteins by Oxidized Catechols as a Potential Mechanism of Lewy Body Formation , 1995, Journal of neuropathology and experimental neurology.
[73] S. Weintraub,et al. Proteomic identification of specific oxidized proteins in ApoE-knockout mice: relevance to Alzheimer's disease. , 2004, Free radical biology & medicine.
[74] A. Schapira. Mitochondria in the aetiology and pathogenesis of Parkinson's disease , 2008, The Lancet Neurology.
[75] T. Hastings,et al. Role of oxidative changes in the degeneration of dopamine terminals after injection of neurotoxic levels of dopamine , 2000, Neuroscience.
[76] D. Graham,et al. Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. , 1978, Molecular pharmacology.
[77] M. Beal. Mitochondria and neurodegeneration. , 2007, Novartis Foundation symposium.
[78] S. Lipton,et al. S-nitrosylation of peroxiredoxin 2 promotes oxidative stress-induced neuronal cell death in Parkinson's disease , 2007, Proceedings of the National Academy of Sciences.
[79] M. Asanuma,et al. L-DOPA treatment from the viewpoint of neuroprotection , 2005, Journal of Neurology.
[80] G. Nappi,et al. Quantitative study of mitochondrial complex I in platelets of parkinsonian patients , 1998, Movement disorders : official journal of the Movement Disorder Society.
[81] M. Cascio,et al. Proteomic analysis of rat brain mitochondria following exposure to dopamine quinone: Implications for Parkinson disease , 2008, Neurobiology of Disease.
[82] Yan Wang,et al. Proteomic Identification of a Stress Protein, Mortalin/mthsp70/GRP75 , 2006, Molecular & Cellular Proteomics.
[83] G. Cohen,et al. Parkinson disease: a new link between monoamine oxidase and mitochondrial electron flow. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[84] P. Yu,et al. Dopamine- and L-beta-3,4-dihydroxyphenylalanine hydrochloride (L-Dopa)-induced cytotoxicity towards catecholaminergic neuroblastoma SH-SY5Y cells. Effects of oxidative stress and antioxidative factors. , 1997, Biochemical pharmacology.
[85] Mark A. Wilson,et al. The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[86] S. Jana,et al. Inhibition of rat brain mitochondrial electron transport chain activity by dopamine oxidation products during extended in vitro incubation: implications for Parkinson's disease. , 2005, Biochimica et biophysica acta.
[87] T. Hastings. Enzymatic Oxidation of Dopamine: The Role of Prostaglandin H Synthase , 1995, Journal of neurochemistry.
[88] T. Montine,et al. Mechanisms of 4-hydroxynonenal-induced neuronal microtubule dysfunction , 2005, Brain Research.
[89] I. Boldogh,et al. Mitochondria on the move. , 2007, Trends in cell biology.
[90] L. Ruddock,et al. The human protein disulphide isomerase family: substrate interactions and functional properties , 2005, EMBO reports.
[91] D. Butterfield,et al. Protein oxidation in the brain in Alzheimer's disease , 2001, Neuroscience.
[92] T. Hirano,et al. Identification and characterization of molecular interactions between mortalin/mtHsp70 and HSP60. , 2005, The Biochemical journal.
[93] D. Brdiczka,et al. The function of complexes between the outer mitochondrial membrane pore (VDAC) and the adenine nucleotide translocase in regulation of energy metabolism and apoptosis. , 2003, Acta biochimica Polonica.
[94] D. Selkoe,et al. Dopamine covalently modifies and functionally inactivates parkin , 2005, Nature Medicine.
[95] Simon C Watkins,et al. Quantitative Biochemical and Ultrastructural Comparison of Mitochondrial Permeability Transition in Isolated Brain and Liver Mitochondria: Evidence for Reduced Sensitivity of Brain Mitochondria , 2000, Experimental Neurology.
[96] J. Borowitz,et al. Dopamine‐Induced Apoptosis Is Mediated by Oxidative Stress and Is Enhanced by Cyanide in Differentiated PC12 Cells , 2000, Journal of neurochemistry.
[97] D. Petersen,et al. Residue-specific adduction of tubulin by 4-hydroxynonenal and 4-oxononenal causes cross-linking and inhibits polymerization. , 2007, Chemical research in toxicology.
[98] M. Kito,et al. Inhibition by acidic phospholipids of protein degradation by ER‐60 protease, a novel cysteine protease, of endoplasmic reticulum , 1992, FEBS letters.
[99] M. Vila,et al. The parkinsonian toxin MPTP: action and mechanism. , 2000, Restorative neurology and neuroscience.
[100] Patrizia Rizzu,et al. Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism , 2002, Science.
[101] M. Carré,et al. Tubulin Is an Inherent Component of Mitochondrial Membranes That Interacts with the Voltage-dependent Anion Channel* , 2002, The Journal of Biological Chemistry.